+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Bronchitis Treatment Market Research Report by Type, Treatment, Class of Drugs, End-user, and State - United States Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 5337331
  • Report
  • October 2021
  • Region: United States
  • 186 Pages
  • 360iResearch™
UP TO OFF
until Jan 01st 2022
United States Bronchitis Treatment Market is Projected to Reach USD 1,831.63 Million by 2026, Registering a CAGR of 9.27%

FEATURED COMPANIES

  • American Well Corporation
  • AstraZeneca PLC
  • Cigna Corporation
  • F. Hoffmann-La Roche Ltd.
  • Novartis International AG
  • Pfizer Inc.
The United States Bronchitis Treatment Market size was estimated at USD 1,076.01 million in 2020, is expected to reach USD 1,204.91 million in 2021, and projected to grow at a CAGR of 9.27% reaching USD 1,831.63 million by 2026.



Market Statistics


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage


This research report categorizes the Bronchitis Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Type, the market was studied across Acute Bronchitis and Chronic Bronchitis.
  • Based on Treatment, the market was studied across Drugs and Oxygen Therapy.
  • Based on Class of Drugs, the market was studied across Anti-inflammatory Drugs, Antibiotics, Bronchodilator, and Others.
  • Based on End-user, the market was studied across Clinics, Hospital Pharmacies, Others, and Retail Pharmacies.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The analyst's ongoing research amplifies their research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Bronchitis Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Bronchitis Treatment Market, including American Well Corporation, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Cigna Corporation, Dr. Reddy’s Laboratories Ltd, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Pharmaceuticals Limited, Johnson & Johnson Services, Inc, Mayo Foundation for Medical Education and Research (MFMER), Melinta Therapeutics, Inc., Novartis International AG, Pfizer Inc., Reckitt Benckiser Group PLC, Sanofi S.A, and TelaCare Health Solutions, LLC.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Bronchitis Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Bronchitis Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Bronchitis Treatment Market?
4. What is the competitive strategic window for opportunities in the United States Bronchitis Treatment Market?
5. What are the technology trends and regulatory frameworks in the United States Bronchitis Treatment Market?
6. What is the market share of the leading vendors in the United States Bronchitis Treatment Market?
7. What modes and strategic moves are considered suitable for entering the United States Bronchitis Treatment Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • American Well Corporation
  • AstraZeneca PLC
  • Cigna Corporation
  • F. Hoffmann-La Roche Ltd.
  • Novartis International AG
  • Pfizer Inc.
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges

6. Bronchitis Treatment Market, by Type
6.1. Introduction
6.2. Acute Bronchitis
6.3. Chronic Bronchitis

7. Bronchitis Treatment Market, by Treatment
7.1. Introduction
7.2. Drugs
7.3. Oxygen Therapy

8. Bronchitis Treatment Market, by Class of Drugs
8.1. Introduction
8.2. Anti-inflammatory Drugs
8.3. Antibiotics
8.4. Bronchodilator
8.5. Others

9. Bronchitis Treatment Market, by End-user
9.1. Introduction
9.2. Clinics
9.3. Hospital Pharmacies
9.4. Others
9.5. Retail Pharmacies

10. California Bronchitis Treatment Market

11. Florida Bronchitis Treatment Market

12. Illinois Bronchitis Treatment Market

13. New York Bronchitis Treatment Market

14. Ohio Bronchitis Treatment Market

15. Pennsylvania Bronchitis Treatment Market

16. Texas Bronchitis Treatment Market

17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis
17.3. Market Share Analysis, by Key Player
17.4. Competitive Scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, Collaboration, & Partnership
17.4.3. New Product Launch & Enhancement
17.4.4. Investment & Funding
17.4.5. Award, Recognition, & Expansion

18. Company Usability Profiles
18.1. American Well Corporation
18.2. AstraZeneca PLC
18.3. Boehringer Ingelheim International GmbH
18.4. Cigna Corporation
18.5. Dr. Reddy’s Laboratories Ltd.
18.6. F. Hoffmann-La Roche Ltd.
18.7. GlaxoSmithKline Pharmaceuticals Limited
18.8. Johnson & Johnson Services, Inc.
18.9. Mayo Foundation for Medical Education and Research (MFMER)
18.10. Melinta Therapeutics, Inc.
18.11. Novartis International AG
18.12. Pfizer Inc.
18.13. Reckitt Benckiser Group PLC
18.14. Sanofi S.A
18.15. TelaCare Health Solutions, LLC

19. Appendix
19.1. Discussion Guide
19.2. License & Pricing

List of Figures
Figure 1. United States Bronchitis Treatment Market Size, 2020 vs 2026 (USD Million)
Figure 2. United States Bronchitis Treatment Market Size, 2018-2026 (USD Million)
Figure 3. United States Bronchitis Treatment Market: Market Dynamics
Figure 4. United States Bronchitis Treatment Market Size, by Type, 2020 vs 2026 (%)
Figure 5. United States Bronchitis Treatment Market Size, by Type, 2020 vs 2026 (USD Million)
Figure 6. Competitive Strategic Window for United States Bronchitis Treatment Market Size, by Type, 2026
Figure 7. United States Bronchitis Treatment Market Size, by Acute Bronchitis, 2018-2026 (USD Million)
Figure 8. United States Bronchitis Treatment Market Size, by Acute Bronchitis, by State, 2020 vs 2026 (USD Million)
Figure 9. United States Bronchitis Treatment Market Size, by Chronic Bronchitis, 2018-2026 (USD Million)
Figure 10. United States Bronchitis Treatment Market Size, by Chronic Bronchitis, by State, 2020 vs 2026 (USD Million)
Figure 11. United States Bronchitis Treatment Market Size, by Treatment, 2020 vs 2026 (%)
Figure 12. United States Bronchitis Treatment Market Size, by Treatment, 2020 vs 2026 (USD Million)
Figure 13. Competitive Strategic Window for United States Bronchitis Treatment Market Size, by Treatment, 2026
Figure 14. United States Bronchitis Treatment Market Size, by Drugs, 2018-2026 (USD Million)
Figure 15. United States Bronchitis Treatment Market Size, by Drugs, by State, 2020 vs 2026 (USD Million)
Figure 16. United States Bronchitis Treatment Market Size, by Oxygen Therapy, 2018-2026 (USD Million)
Figure 17. United States Bronchitis Treatment Market Size, by Oxygen Therapy, by State, 2020 vs 2026 (USD Million)
Figure 18. United States Bronchitis Treatment Market Size, by Class of Drugs, 2020 vs 2026 (%)
Figure 19. United States Bronchitis Treatment Market Size, by Class of Drugs, 2020 vs 2026 (USD Million)
Figure 20. Competitive Strategic Window for United States Bronchitis Treatment Market Size, by Class of Drugs, 2026
Figure 21. United States Bronchitis Treatment Market Size, by Anti-Inflammatory Drugs, 2018-2026 (USD Million)
Figure 22. United States Bronchitis Treatment Market Size, by Anti-Inflammatory Drugs, by State, 2020 vs 2026 (USD Million)
Figure 23. United States Bronchitis Treatment Market Size, by Antibiotics, 2018-2026 (USD Million)
Figure 24. United States Bronchitis Treatment Market Size, by Antibiotics, by State, 2020 vs 2026 (USD Million)
Figure 25. United States Bronchitis Treatment Market Size, by Bronchodilator, 2018-2026 (USD Million)
Figure 26. United States Bronchitis Treatment Market Size, by Bronchodilator, by State, 2020 vs 2026 (USD Million)
Figure 27. United States Bronchitis Treatment Market Size, by Others, 2018-2026 (USD Million)
Figure 28. United States Bronchitis Treatment Market Size, by Others, by State, 2020 vs 2026 (USD Million)
Figure 29. United States Bronchitis Treatment Market Size, by End-user, 2020 vs 2026 (%)
Figure 30. United States Bronchitis Treatment Market Size, by End-user, 2020 vs 2026 (USD Million)
Figure 31. Competitive Strategic Window for United States Bronchitis Treatment Market Size, by End-user, 2026
Figure 32. United States Bronchitis Treatment Market Size, by Clinics, 2018-2026 (USD Million)
Figure 33. United States Bronchitis Treatment Market Size, by Clinics, by State, 2020 vs 2026 (USD Million)
Figure 34. United States Bronchitis Treatment Market Size, by Hospital Pharmacies, 2018-2026 (USD Million)
Figure 35. United States Bronchitis Treatment Market Size, by Hospital Pharmacies, by State, 2020 vs 2026 (USD Million)
Figure 36. United States Bronchitis Treatment Market Size, by Others, 2018-2026 (USD Million)
Figure 37. United States Bronchitis Treatment Market Size, by Others, by State, 2020 vs 2026 (USD Million)
Figure 38. United States Bronchitis Treatment Market Size, by Retail Pharmacies, 2018-2026 (USD Million)
Figure 39. United States Bronchitis Treatment Market Size, by Retail Pharmacies, by State, 2020 vs 2026 (USD Million)
Figure 40. United States Bronchitis Treatment Market: FPNV Positioning Matrix
Figure 41. United States Bronchitis Treatment Market: Share, by Key Player, 2020
Figure 42. Competitive Scenario Analysis in United States Bronchitis Treatment Market, by Type

List of Tables
Table 1. United States Bronchitis Treatment Market: Market Segmentation & Coverage
Table 2. United States Dollar Exchange Rate, 2016–2020
Table 3. United States Bronchitis Treatment Market Size, 2018-2026 (USD Million)
Table 4. United States Bronchitis Treatment Market Size, by Type, 2018-2026 (USD Million)
Table 5. United States Bronchitis Treatment Market Size, by Acute Bronchitis, by State, 2018-2026 (USD Million)
Table 6. United States Bronchitis Treatment Market Size, by Chronic Bronchitis, by State, 2018-2026 (USD Million)
Table 7. United States Bronchitis Treatment Market Size, by Treatment, 2018-2026 (USD Million)
Table 8. United States Bronchitis Treatment Market Size, by Drugs, by State, 2018-2026 (USD Million)
Table 9. United States Bronchitis Treatment Market Size, by Oxygen Therapy, by State, 2018-2026 (USD Million)
Table 10. United States Bronchitis Treatment Market Size, by Class of Drugs, 2018-2026 (USD Million)
Table 11. United States Bronchitis Treatment Market Size, by Anti-Inflammatory Drugs, by State, 2018-2026 (USD Million)
Table 12. United States Bronchitis Treatment Market Size, by Antibiotics, by State, 2018-2026 (USD Million)
Table 13. United States Bronchitis Treatment Market Size, by Bronchodilator, by State, 2018-2026 (USD Million)
Table 14. United States Bronchitis Treatment Market Size, by Others, by State, 2018-2026 (USD Million)
Table 15. United States Bronchitis Treatment Market Size, by End-user, 2018-2026 (USD Million)
Table 16. United States Bronchitis Treatment Market Size, by Clinics, by State, 2018-2026 (USD Million)
Table 17. United States Bronchitis Treatment Market Size, by Hospital Pharmacies, by State, 2018-2026 (USD Million)
Table 18. United States Bronchitis Treatment Market Size, by Others, by State, 2018-2026 (USD Million)
Table 19. United States Bronchitis Treatment Market Size, by Retail Pharmacies, by State, 2018-2026 (USD Million)
Table 20. United States Bronchitis Treatment Market: Scores
Table 21. United States Bronchitis Treatment Market: Business Strategy
Table 22. United States Bronchitis Treatment Market: Product Satisfaction
Table 23. United States Bronchitis Treatment Market: Ranking
Table 24. United States Bronchitis Treatment Market: Share, by Key Player, 2020
Table 25. United States Bronchitis Treatment Market: Merger & Acquisition
Table 26. United States Bronchitis Treatment Market: Agreement, Collaboration & Partnership
Table 27. United States Bronchitis Treatment Market: New Product Launch & Enhancement
Table 28. United States Bronchitis Treatment Market: Investment & Funding
Table 29. United States Bronchitis Treatment Market: Award, Recognition & Expansion
Table 30. United States Bronchitis Treatment Market: License & Pricing
Note: Product cover images may vary from those shown
  • American Well Corporation
  • AstraZeneca PLC
  • Boehringer Ingelheim International GmbH
  • Cigna Corporation
  • Dr. Reddy’s Laboratories Ltd
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Pharmaceuticals Limited
  • Johnson & Johnson Services, Inc
  • Mayo Foundation for Medical Education and Research (MFMER)
  • Melinta Therapeutics, Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Reckitt Benckiser Group PLC
  • Sanofi S.A
  • TelaCare Health Solutions, LLC
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll